NorthWest Biotherapeutics Inc (NWBO)

[abeta]

If nwbo does submit in the UK, I expect it to be rejected. Results are marginal once adjusted for nwbo advantages over competitors in full resection, KPS score, patient health, etc. No patient level data. Way too many warts on a 15+ year trial that went from P2 to P3, upsize, unexplained FDA halt, unbalanced enrollment, etc.

All those ALIVE patients are a real pain in the ass.

When the UK approves - will Adam retract his Dec 2013 hit piece?.

Canada and the USA won't be far behind.

Will Adam then retract his Dec 2013 hit piece?